Justin Marson
Internal Medicine · Brooklyn, NYNPI 1831650548
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 251 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 22.4% — the pattern of someone who eats at a lot of different presentations. Among internal medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 251 payments — averaging $71.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sun Pharmaceutical Industries Inc.$4K
- Dermavant Sciences, Inc.$2K
- Incyte Corporation$2K
- E.r. Squibb & Sons, L.L.C.$1K
- UCB, Inc.$966
- Janssen Scientific Affairs, LLC$945
- plus $7K from 19 others
What the payments were for
- Food & beverage$17,974100%
- Education$690%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sun Pharmaceutical Industries Inc. | 48 | $4,049 |
| Dermavant Sciences, Inc. | 24 | $2,386 |
| Incyte Corporation | 21 | $1,530 |
| E.r. Squibb & Sons, L.L.C. | 20 | $1,321 |
| UCB, Inc. | 16 | $966 |
| Janssen Scientific Affairs, LLC | 9 | $945 |
| Novartis | 12 | $901 |
| Sanofi | 10 | $890 |
| Pfizer | 8 | $671 |
| AbbVie | 14 | $618 |
| LEO Pharma Inc. | 9 | $552 |
| Boehringer Ingelheim | 8 | $467 |
| Arcutis Biotherapeutics, Inc. | 9 | $445 |
| Galderma Laboratories, L.p. | 6 | $429 |
| Lilly USA, LLC | 10 | $312 |
| Blueprint Medicines Corporation | 3 | $293 |
| Verrica Pharmaceuticals Inc. | 2 | $272 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 3 | $242 |
| Helsinn Therapeutics (U.S.), Inc. | 5 | $186 |
| Chiesi USA, Inc. | 4 | $165 |
| Organon | 1 | $150 |
| Johnson & Johnson | 3 | $107 |
| Amgen | 3 | $67 |
| Regeneron Healthcare Solutions, Inc. | 2 | $59 |
| Almirall LLC | 1 | $20 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$18,043 in reported general payments places this provider in the 95th percentile of 9,771 internal medicine providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tacrolimus | 32 | $8,857 |
| Ketoconazole | 37 | $1,220 |
| Triamcinolone Acetonide | 26 | $292 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Brooklyn
- Bruce BergerBrooklyn$3.4M
- Jesi RamoneBrooklyn$627K
- Manish ParikhBrooklyn$236K
- Samuel UterBrooklyn$136K
- David DoveEast Hampton$12.3M
- Nicholas RobinsonBuffalo$2.9M
- Stephen SaletanNew York$2.6M
- Ziad AliNew York$2M
- Scott BeegleAlbany$1.9M
- Anthony MartinezBuffalo$1.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.